• ASO F. SALIH Department of Pediatrics, School of Medicine, Faculty of Medical Sciences, University of Sulaimani, Kurdistan Region, Iraq
  • ADNAN M HASAN Department of Pediatrics, School of Medicine, Faculty of Medical ***Sciences, University of Sulaimani, Kurdistan Region, Iraq.
  • JAMAL A. RASHID Department of Pediatrics, School of Medicine, Faculty of Medical Sciences, University of Sulaimani, Kurdistan Region, Iraq.
Keywords: Kawasaki disease, Echocardiography, Coronary disease



Background: Kawasaki disease is the most common cause of acquired heart disease in developed countries. Kawasaki disease it has been increasingly reported from developing countries. The aim of this study was to assess the clinical and epidemiological characteristics of Kawasaki disease in children of Sulaimaniyah city.

Subject and Methods: In this study all children diagnosed as Kawasaki disease included during the period between January 2010 and December 2014. The hospital records / pediatric cardiology clinic data were reviewed, and data were abstracted onto standardized forms.

Results: During the study period from January 2010 to December 2014, 36 patients were diagnosed as Kawasaki disease. Their mean age at diagnosis was 2.8± 2 years (range 6 months -9years). Most of the patients (30 patients 83.3%) were under age of 5 years, and the median age was 2.1 year. Male to female ratio was 1.76. Most of cases occurred during winter and spring season. Out of 36 patients, 16 (44.4%) patients had coronary disease, and 4 cases of coronary cases were classified as A4 and A5 class according to Japanese Classification of Severity of Coronary Artery Lesions. There was non-significant difference between coronary and non-coronary group regarding hemoglobin level, platelet count, ESR and WBC count.

Conclusions: Kawasaki disease is not uncommon in Sulaymaniyah, the clinical and epidemiological pattern is not different from other parts of the world. We need to increase the index of suspicion in order not to miss Kawasaki disease cases and avoid its serious cardiac complications.


Download data is not yet available.


1- Barron KS .Kawasaki disease in children.Curr Opin Rheum. 1998, 10(1):29-37.
2- Kawasaki T. Acute febrile mucocutaneous lymph node syndrome with accompanying specific peeling of the fingers and the toes. Allergy 1967:178-222.
3- Burns JC, Glode MP. Kawasaki syndrome. Lancet. 2004: 533-544.
4- Holman R.C., Curns A.T., Belay E.D., Steiner CA, and Schonberger LB. Kawasaki syndrome:Hospitalizations in the United States,1997 and 2000. Pediatrics. 2003; 112:495-501.
5- Stockheim J. A., Innocentini N., and Shulman S. T. Kawasaki disease inolder children and adolescents. J. Pediatr. 2000; 137:250-252.
6- Yanagawa H., Nakamura Y., Yashiro M., Uehara R, Oki I, Kayaba K. Incidence of Kawasaki disease in Japan: The nationwide surveys of 1999-2002. Pediatr. Int. 2006; 48:356-361.
7- Japanese Circulation Society Joint Working Group. Guideline for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013)-digest version. Circ J. 2014; 7 8:2521 – 2562 www.jcirc.or.jp/guideline/pdf/JCS2013_ogawas_d.pdf.
8- Melish ME, Marchette MJ, Kaplan JC, Kihara S, Ching D, Ho DD. Absence of significant RNA-dependent DNA polymerase activity in lymphocytes from patients with Kawasaki syndrome. Nature. 1989; 337:288-290.
9- Hirata S, Nakamura Y, Matusmoto K,Yanagawa H. Long-term consequences of Kawasaki disease among first-year junior high school students. Arch Pediatr Adolesc Med. 2002; 156 (1):77-80.
10- Lai W, Mertens LL, Cohen MS, GevaT. Echocardiography in Pediatric and Congenital Heart Disease: From Fetus to Adult. eds 2009 Wiley-Blackwell Appendix 1: Normal Values for Cardiovascular Structures. http://onlinelibrary.wiley.com/doi/10.1002/9781444306309.app1/pdfaccessed on August 18th 2011.
11- Al-Harbi K. M.Kawasaki disease in western Saudi Arabia. Saudi Med J. 2010; 31(11):1217-1220.
12- Kim SH, Kim KH, Kim DS. Clinical Characteristics of Kawasaki Disease According toAge at Diagnosis. Indian Pediatrics. 2009; 46(17):585-590.
13- Ahmad S., Farah S. Kawasaki disease in Iran A report of 85 cases Iranianjournal ofpediatric society. 2007; 1(2):9-12.
14- Mei-Chen T., Li-Chieh W. , Hsin-Hui Y. , Jyh-Hong L. , Yao-Hsu Y. , Bor-Luen C. Kawasaki disease and Henoch Schonlein purpura - 10 years’ experience of childhood vasculitis at a university hospital in Taiwan. Journal of Microbiology, Immunology and Infection. 2012; 45:22-30.
15- Mohammad M., Abdolrazagh K. Kawasaki disease in Iranian children. Iran J Pediatr. 2007; 17 (3):241-246.
16- A.Lardhi . A Kawasaki disease: A university hospital experience. Saudi journal of medicine and medical science. 2013; 1(1): 35-39.
17- Shamsizadeh A, Kajbaf T, Razavi M, and Chreaghian B. Clinical and epidemiological characteristics. jundishapur J Microbiol. 2014; 7(8): e11014.
18- Chang RK. Hospitalizations for Kawasaki disease among chil¬dren in the United States, 1988-1997. Pediatrics. 2002; 109(6):e87.
19- Huang WC, Huang LM, Chang IS, Chang LY, Chiang BL, Chen PJ, Wu MH, Lue HC, Lee CY. Epidemiologic features of Kawasaki disease in Taiwan, 2003- 2006. Pediatrics. 2009; 123(3):e401–5.
20- Park YW, Han JW Park IS, Kim CH, Cha SH, Ma JS Lee JS, Kwon TC Lee SB et al . Kawasaki disease in Korea, 2003-2005. Pediatr Infect Dis J. 2007; 26 (9):821–3.
21- Özdemir H, Çiftçi E, Tapısız A, İnce E, Tutar E, Atalay S et al. Clini¬cal and epidemiological characteristics of children with Kawa-saki disease in Turkey. J Trop Pediatr. 2010; 56(4):260–2.
22- Singh S, Bansal A, Gupta A, Kumar RM, Mittal BR. Kawasaki disease: a decade of experience from North India. Int Heart J. 2008; 46(4):679–689.
23- Du ZD, Zhang T, Liang L, Meng X, Li T, Kawasaki T, et al. Epidemio-logic picture of Kawasaki disease in Beijing from 1995 through 1999. Pediatr Infect Dis J. 2002; 21(2):103–7.
24- Hiromi M, Masahiro I, Mayumi Y, Ritei U, and Yosikazu N. Late intravenous immunoglobulintreatment in patients with Kawasaki disease. Pediatrics. 2012; 129(2); e291– e297.
25- Kushner HI, Bastian JF, Turner CH, Burns JC. Rethinking the boundaries of Kawasaki disease: toward a revised case definition. Perspect. Biology Med. 2003; 46(2):216-33.
26- Sundel RP, Burns JC, Baker A, Beiser AS, Newburger JW. Gamma globulin re-treatment inKawasaki disease. J Pediatr.1993; 123(4):657-9.
27- Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C, Klein N, Booy R, Levin M, Dillon MJ. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child. 2002; 86(4):286-90.
28- Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin resistant Kawasaki disease with pulsed doses of corticoid steroids. J Pediatr. 1996; 128(1):146-9.
29- Nathan J. and Davinder S.G. Kawasaki Disease: A Clinician’s Update. International journal of pediatrics. 2013; article ID645391, 7 pages,http://dx.doi.org/10.1155/2013/645391
How to Cite
SALIH, A. F., HASAN, A. M., & RASHID, J. A. (2018). KAWASAKI DISEASE IN SULAYMANIYAH/ KURDISTAN/ IRAQ. Duhok Medical Journal, 11(2), 37-45. Retrieved from https://dmj.uod.ac/index.php/dmj/article/view/20